ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

ArQule, Inc. 

19 Presidential Way

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-994-0300 Fax: 781-376-6019


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery

Collaborations

Roche 

Pfizer Inc. 

Daiichi Sankyo, Inc. 





 Company News
ArQule, Inc. (ARQL) To Present At Needham 13th Annual Healthcare Conference 4/2/2014 7:45:15 AM    More...
ArQule, Inc. (ARQL) Reports Fiscal 2013 Year End And Fourth Quarter Results 3/5/2014 9:01:20 AM    More...
ArQule, Inc. (ARQL) To Report Fiscal 2013 Financial Results On March 5, 2014 2/26/2014 7:39:48 AM    More...
ArQule, Inc. (ARQL) To Present At RBC Capital Markets Healthcare Conference 2/18/2014 6:46:17 AM    More...
ArQule, Inc. (ARQL) Announces Commencement Of Phase 3 Clinical Trial With Tivantinib In Hepatocellular Carcinoma By Partner Kyowa Hakko Kirin In Japan 2/4/2014 9:46:24 AM    More...
ArQule, Inc. (ARQL) Soars As FDA Panel Favors Continuation Of Liver Cancer Drug Study, Stock Up +6.78% At Market Close (January 17, 2014) 1/17/2014 8:28:01 AM    More...
ArQule, Inc. (ARQL) Announces Third Quarter Fiscal 2013 Results 11/7/2013 8:07:14 AM    More...
ArQule, Inc. (ARQL) to Report Third Quarter 2013 Financial Results on November 7, 2013 10/31/2013 8:24:52 AM    More...
ArQule, Inc. (ARQL) Release: Data Presented at European Cancer Congress Suggest Clinical Benefit of Tivantinib in Patients With MET High Non-Squamous Non-Small Cell Lung Cancer 9/30/2013 9:53:46 AM    More...
ArQule, Inc. (ARQL) Release: Data Presented at European Cancer Congress Suggest Clinical Benefit of Tivantinib in Patients with MET High Non-Squamous Non-Small Cell Lung Cancer 9/30/2013 7:00:55 AM    More...
12345678910...